Novartis updates mid-term outlook as Q4 profit up

Swiss pharma major Novartis on Wednesday updated its mid-term guidance as it reported a fourth-quarter net income of $8.48 billion, up from last year’s $1.47 billion. Earnings per share were $4.14, significantly higher than $0.69 a year ago. Looking ah…